Login | New Member? Signup Free
ChangeDetect » News

Latest News

HARTFORD — Since the federal Food and Drug Administration has failed to test genetically modified foods for potential safety risks, the General Assembly is well within its power to require labels on hundreds of such products.

Tags: , , , , , , ,

1 Number All Biotech Investors Need to Watch

In the world of biotech investing, stocks can either soar or plummet depending on clinical trial results. This industry is filled with small-cap companies working toward approval from the Food and Drug Administration and spending millions of dollars on clinical development.

Tags: , , , , , , ,

Press Release

The U.S. Food and Drug Administration has approved Dymista, a new patented product for treatment of seasonal allergic rhinitis . In several clinical studies, Dymista has consistently showed a rapid and more complete symptom relief than standard treatment.

Tags: , , , , ,

FDA allows marketing of Stratify JCV Antibody ELISA test for PML

Today, the U.S. Food and Drug Administration allowed marketing of the first test to help determine the risk for a rare brain infection called progressive multifocal leukoencephalopathy in people using the drug Tysabri to treat multiple sclerosis or Crohn's disease.

Tags: , , , , , , , , , , , ,

FDA grants Fast Track designation for DARA’s KRN5500 neuropathic pain relief drug

DARA BioSciences, Inc. announced today that its investigational drug KRN5500 has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of chemotherapy-induced neuropathic pain in patients with cancer. (12 hours ago)

Tags: , , , , , , , , , , ,

FDA ODAC recommends approval of Seattle Genetics’ ADCETRIS for Hodgkin lymphoma after ASCT

Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee to the U.S. Food and Drug Administration voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS? for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant . (1 hour ago)

Tags: , , , , , , , , , , , ,

Eisai’s DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration has accepted for review its supplemental New Drug Application seeking approval of DACOGEN for injection in the treatment of acute myeloid leukemia. (3 hours ago)

Tags: , , , , , , , , , , , , ,